Funny thing is, vax rabbit. Vaxxing in the midst of a pandemic CREATES variants. You should bone up on the science before you pop off at the mouth.
Start with Darwin and 'survival of the fittest' and go from there.
#ScienceDenier
Posted on 09/23/2021 10:00:20 PM PDT by ransomnote
[H/T Grey_Whiskers]
If you find yourself confused about the mixed guidance when it comes to Covid-19 vaccines and safety concerns, you’re not alone.
While the Centers for Disease Control (CDC) is marketing widespread use of the emergency-use vaccines in the U.S. for both old and young alike, many other countries are limiting Covid-19 vaccine use. Health officials around the world are giving varying advice on safety issues as Covid-19 vaccines are given to more people, and more information can be collected.
Below are summaries of some of the concerns that have emerged or been raised by medical officials.
In the UK, some scientists analyzed adverse event reports and called upon the Medicines and Healthcare Products Regulatory Agency to stop the Covid-19 vaccines as “not safe for human use” due to reports of issues with bleeding/clotting, pain, immune system, neurological, loss of sight/hearing/smell/speech, and questions about impact in pregnant women.
A petition of scientists led by Linda Wastila, Professor, Pharmaceutical Health Services Research University of Maryland School of Pharmacy is calling for Covid-19 vaccines to be disapproved.
Fifty-seven authors from 17 countries have signed an endorsement urging that Covid-19 vaccinations be stopped unless new safety mechanisms are immediately implemented.
The authors include Dr. Peter McCullough, cardiologist and former Vice Chief of Medicine at Baylor University Medical Center in Dallas, Texas, who has called for a halt to vaccinating 30-year olds due to “no clinical benefit” and safety concerns. [McCullough is currently Senior Professor of Internal Medicine at the Texas A&M University Health Sciences Center.]
Updated Sept. 19, 2021: All brands of Covid-19 vaccines are associated in changes in menstrual cycles of women, according to a British study.
Biologically plausible mechanisms linking immune stimulation with menstrual changes include immunological influences on the hormones driving the menstrual cycle or effects mediated by immune cells in the lining of the uterus, which are involved in the cyclical build-up and breakdown of this tissue. Research exploring a possible association between covid-19 vaccines and menstrual changes may also help understand the mechanism.Menstrual changes after covid-19 vaccination
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with an increased risk of lymphadenopathy, swelling or inflammation of lymph nodes according to a real-world case-control study from Israel.
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with increased risk of appendicitis, according to a real-world case-control study from Israel.
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with an increased risk of herpes zoster infection, according to a real-world case-control study from Israel.
A new study in Journal of Neurology examines possible links between Pfizer and Moderna vaccines, and acute Central Nervous System (CNS) demyelination, including Multiple Sclerosis (MS).
Demyelinating diseases damage the protective covering surrounding nerve fibers in the brain, optic nerves and spinal cord, causing neurological problems. In the study, four patients had the Pfizer vaccine and three had the Moderna vaccine. Within 21 days of the first or second dose, the patients developed active CNS demyelination of the optic nerve, brain, and/or spinal cord leading to "visual loss, dysmetria, gait instability, paresthesias, sphincter disturbance, and limb weakness."
Age ranged from 24 to 64 years old. Four patients were ultimately diagnoses with exacerbation of their stable MS.
Two were diagnosed with new cases of MS.
One was diagnosed with neuromyelitis optica.
Researchers in the United Kingdom are studying two additional cases of Functional Neurological Disorder (FND) in women in their 30s after receiving Covid-19 vaccines.
FND is a neurological disorder involving malfunctioning of the nervous system and how the brain and body transmit signals. Symptoms can include limb weakness, paralysis, tremor, spasms, problems walking, speech problems, tingling, vision loss, seizures, fatigue, anxiety, chronic pain, memory symptoms, and blackouts.
An analysis of Covid-19 vaccine adverse events showed hundreds of thousands of reports of such symptoms.
In January, videos showing vaccine patients suffering such symptoms were treated by media outlets such as Wired as if they were fake news and "dangerous" misinformation.
In fact, the videos garnered the attention of scientists who investigated and concluded they were early warnings of what happens to some who get Covid-19 vaccines.
The newest cases are outlined in the journal NeuroPsychiatry and include:
Updated (read more here). According to studies:
Update July 22, 2021: The European Union added Guillain-Barré syndrome, an autoimmune paralysis disorder, as a possible side effect from Johnson and Johnson's Covid-19 vaccine.
Update July 12, 2021: The FDA added warnings about Guillain-Barre autoimmune paralysis, in which the immune system attacks the body's nerves, after Johnson and Johnson vaccine. According to reports, the cases have primarily been reported about two weeks after vaccination, mostly in men, and "any aged 50 and older."
Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that "all physicians" should be "vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine... our observations suggest that this clinically distinct [Guillain-Barré syndrome] variant is more severe than usual and may require mechanical ventilation." In the U.K., scientists flagged "bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine." A case has also been reported in a patient who got the Pfizer vaccine. In India, there are reports of seven severe cases of Guillain-Barré syndrome 10 to 14 days after the first dose of AstraZeneca's vaccine. Six were women, all had facial paralysis, "all progressed to quadriplegia, and six required respiratory support. Patients' ages ranged from 43 to 70. Four developed other cranial neuropathies, including abducens palsy and trigeminal sensory nerve involvement."
Guillain-Barre syndrome has been reported after other vaccinations. The cause is believed to be damage to the immune system. The disorder can be extremely serious and can lead to total paralysis with dependence on artificial respiration. Even those who recover may have serious muscle wasting and may have to slowly teach the body to relearn most every normal task, such as walking. One in 20 cases is fatal.
Updated Aug. 17: An analysis in Hong Kong shows risk of Bell's palsy is higher with CoronaVac (Sinovac Biotech) shot, a vaccine formulation not currently used in U.S. Bell's palsy is facial paralysis, muscle twitching, or weakness. It may include change in taste, and pain around the ear, increased sensitivity to sound known as hyperacusis. An adverse event analysis of U.S. reports shows 4,154 Bell’s Palsy after Covid-19 vaccination.
Updated Sept. 9, 2021: The Pfizer COVID-19 mRNA vaccine was found to be associated with a threefold increased risk of myocarditis, according to a real-world case-control study from Israel. "Vaccination had a strong association with an increased risk of myocarditis as well as increased risks of lymphadenopathy [swelling or inflammation of lymph nodes], appendicitis, and herpes zoster infection."
The Food and Drug Administration has added a new warning to Pfizer and Moderna Covid-19 vaccines about risk of heart inflammation.
As of June of 2021, CDC said that more than 1,200 cases of heart inflammation (myocarditis or pericarditis) in young people had been reported after Pfizer and Moderna Covid-19 vaccination.
Updated Aug. 4: A new, independent study of medical records found the incidences of myocarditis and pericarditis are more than five times more common than CDC reported.
The Israeli Ministry of Health announced it’s monitoring for heart inflammation after Pfizer's vaccine due to reports of problems.
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines [Pfizer-BioNTech, Moderna] in a number of patients are described in a scientific article:
According to the research:
Updated Sept.9, 2021: An August 10 study in JAMA Cardiology confirms the previously identified Pfizer vaccine's myocarditis (heart inflammation) risk in young boys.
Updated Sept. 12, 2021: A study of Pfizer and Moderna vaccines finds teenage boys are six times more likely to suffer heart issues from Covid-19 vaccination than from Covid. (However, in both instances, the risk is considered slight.)
In late June, the first case of a blood clot disorder called "thrombosis with thrombocytopenia" after an RNA double-dose vaccine was been reported in the Annals of Internal Medicine. The case was that of a 65-year-old man who developed symptoms ten days after his second dose of the Moderna vaccine. Because the blood clot disorder was not previously warned about in the Moderna and Pfizer vaccines, doctors treated the patient with heparin, the very drug that's not supposed to be used in post-vaccine patients suffering from the disorder because it could actually worsen the condition.
The Johnson and Johnson Covid-19 vaccine was temporarily removed from the market in the U.S. on April 16, 2021 while health officials studied reports of blood clot injuries. Among them was an 18-year old teen named Emma Burkey, who got sick about a week after the Johnson and Johnson Covid-19 vaccine and ended up having three brain surgeries related to blood clots and seizures.
Read: BBC radio news anchor dies of blood clots after Covid vaccine
The Johnson and Johnson vaccine was allowed back on the market April 27, 2021 with new warnings about the disorder.
Swedish health officials determined that people under age 65 should not get the Johnson and Johnson vaccine due to reports of blood clots.
An editorial published in the Journal of the American Medical Association recommended women under age 50 avoid the Johnson and Johnson Covid-19 vaccine due to concerns about blood clots. The recommendation discussed 12 case reports of a blood disorder known as cerebral venous sinus thrombosis (CVST) with thrombocytopenia following the Johnson and Johnson vaccine.
The AstraZeneca Covid-19 vaccine (not currently approved in the U.S.) has been linked to a dangerous disorder involving blood clots with low blood platelets. On April 7, 2021, the European Medicines Agency says it made the association after it analyzed 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of March 22, 2021; 18 of which were fatal.
An otherwise healthy South Florida doctor, Gregory Michael, died of a brain hemorrhage 16 days after he got Pfizer’s Covid-19 vaccine. Authorities concluded he died of a blood disorder called “immune thrombocytopenia” (ITP) that can prevent blood from clotting and cause internal bleeding. His wife said a blood test showed the level of his platelets to be at “zero.” She said before the shot, Dr. Michael had “absolutely no medical issues” and no underlying conditions. However, authorities later categorized his death as “natural.”
In Spain, the AstraZeneca shot has been restricted in people under age 60 due to reports of blood clots in younger people.
Bulgaria, Iceland and Norway have halted AstraZeneca shots.
Austria, Italy and Romania banned certain "lots" or batches of the AstraZeneca shots.
Denmark stopped using the AstraZeneca Covid-19 vaccine altogether as well as the Johnson and Johnson vaccine after investigations into blood clots, saying "the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine."
The Italian government recently restricted AstraZeneca Covid-19 vaccine to adults over age 60 after a teenager who got the shot died from a rare form of blood clotting. Eighteen-year-old Camilla Canepa died after getting vaccinated May 25, 2021.
Several other European countries have also stopped giving the AstraZeneca Covid-19 vaccine to people below a certain age, usually ranging from 50 to 65.
Updated Sept. 9, 2021: An August 10 study in JAMA Cardiology urged caution in giving Covid-19 vaccine to certain high risk patients due to the vaccine link to a serious blood disorder: thrombocytopenia with thrombosis. "One of the devastating manifestations of this syndrome, termed vaccine-induced immune thrombotic thrombocytopenia (VITT), is cerebral venous sinus thrombosis (CVST)," say the study authors. The link involves the AstraZeneca/Oxford and Johnson & Johnson vaccines, according to the study. The AstraZeneca vaccine is not administered in the U.S. currently.
Studies in Mexico and Turkey link the autoimmune thyroid disorder Graves disease to Covid-19 vaccination in numerous female health care workers, including two who were breastfeeding. Pfizer-BioNTech was the vaccine given in Mexico. A Chinese vaccine was given in Turkey. Read more at the link below.
Health officials in Norway sounded the alarm after 23 patients died shortly after getting the Pfizer Covid-19 vaccine. They advise doctors to use caution in administering the shot to "very frail elderly patients.”
After investigating 13 of the deaths, the Norwegian authorities concluded that common side effects from so-called "RNA" vaccines may be too much for a frail elderly person to handle, and may contribute to their death.
“There is a possibility that these common adverse reactions, that are not dangerous in fitter, younger patients and are not unusual with vaccines, may aggravate underlying disease in the elderly,” said Steinar Madsen, medical director of the Norwegian Medicines Agency.
CDC said it is monitoring the impact of the vaccines on already-frail patients such as the chronically ill in nursing homes.
Several clusters of elderly patients in U.S. nursing homes died after Pfizer or Moderna Covid-19 vaccine. In one group, a number of the patients who died tested positive for Covid-19 after vaccination.
Several Brazilian states suspended use of AstraZeneca’s Covid-19 vaccine for pregnant women in May 2021 after a pregnant woman died after getting vaccinated. The decisions follow the recommendation of the country’s National Health Surveillance Agency, which recommended "immediate suspension" of the AstraZeneca Covid-19 vaccine for pregnant women after results of vaccine adverse events monitoring in the country.
CDC says that with limited data on impact of Covid-19 vaccine in pregnant women and on their unborn children, the decision on whether to vaccinate while pregnant is an individual decision to be made between a woman and her physician.
CDC falsely claimed that studies showed Covid-19 vaccines are effective for those who already had Covid-19. In fact, studies showed the opposite.
On June 11, the European Union’s drug regulator announced it will not use batches of the Johnson & Johnson COVID-19 vaccine that were made at a Baltimore, Maryland-based plant around the time that cross-contamination manufacturing problems were reported at the facility.
Anonymous sources claimed that up to 60 million doses of the Johnson and Johnson vaccine had to be thrown out. But the FDA issued a news release saying that two batches from the Baltimore plant were safe to use. The FDA said “several other batches are not suitable for use, but additional batches are still under review.”
Israel announced that about half of the adults infected with Covid-19 during its outbreak in the June 2021 time period were fully vaccinated. The fully-vaccinated individuals had gotten Pfizer’s shots.
According to Epoch Times, in June 2021 nearly 4,000 fully vaccinated people in Massachusetts tested positive for Covid-19. On April 30, “the CDC reported that some 10,626 breakthrough cases were reported in 46 states and territories." Breakthrough cases are where fully vaccinated people still end up infected with Covid-19.
Scientists hoped that Covid-19 vaccines would be effective in variants of Covid-19, which are mutations that occur naturally with viruses and were always expected with Covid-19. However, the vaccine effectiveness against variants may be limited. CDC and vaccine makers are studying the medical landscape to find out more.
Other states, such as Maine, are noting Covid-19 deaths occurring in fully vaccinated people.
Update Aug. 24, 2021: With evidence of seriously-waning immunity at the five- to six-month mark, CDC is now recommending a third "booster" shot. In highly-vaccinated Israel, recognition that vaccination likely does not confer protection beyond a few months, the country has reimagined its vaccine passports. They will only apply to people who have had three shots, and only be good for a six month period of time.
Update Sept. 10, 2021: An analysis of data in Israel, which has one of the world's highest Covid-19 vaccination levels, showed almost 60% of those hospitalized for Covid were fully vaccinated. "This is a very clear warning sign for the rest of the world," said Ran Balicer, CIO at Clalit Health Services, Israel's largest health maintenance organization. "If it can happen here, it can probably happen anywhere." The Pfizer vaccine is given in Israel.
MUCH MORE EXCELLENT INFORMATION AT LINK.
THE NEXT SECTION IS SAFTEY CONCERN BY VACCINE.
Canadian info:
Myocarditis is inflammation of the heart muscle and pericarditis is inflammation of the lining around the heart.
Up to and including September 10, 2021, there were 718 confirmed reports of myocarditis/pericarditis that met Level 1 to 4 of Brighton Collaboration level of diagnostic certainty. Of the myocarditis/pericarditis reports:
408 reports followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, 290 followed vaccination with a Moderna Spikevax COVID-19 vaccine, 18 followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, and the vaccine name of two were unspecified
Among the 408 reports of myocarditis/pericarditis following Pfizer-BioNTech Comirnaty COVID-19 vaccine (administered to those 12 years of age and older):
Symptoms started between 5 minutes and 94 days after vaccination
Median age is 29 years (age range 12 to 87 years old)
258 were males [median age 23 years (age range 12 to 82 years old)], 146 were females [median age 39 years (age range 12 to 87 years old)], and the sex of four were unspecified
176 reports following the first vaccine dose, 183 reports following the second vaccine dose, and the dose number for 49 were not specified
Current analyses show the number of reports of myocarditis/pericarditis following the Pfizer-BioNTech Comirnaty COVID-19 vaccine is higher than what would be expected in the general population of males and females less than 30 years old and following the second dose.
Among the 290 reports of myocarditis following vaccination with a Moderna Spikevax COVID-19 vaccine (administered to those 12 years of age and older):
Symptoms started between 14 minutes and 69 days after vaccination
Median age is 28 years (age range 18 to 95 years old)
211 were males [median age 26 years (age range 18 to 95 years old)], 75 were females [median age 35 years (age range 18 to 76)], the sex of one was ‘other’, and the sex of three were unspecified
59 reports following the first vaccine dose, 199 reports following the second vaccine dose, and the dose number for 32 were unspecified
Current analyses show the number of reports of myocarditis/pericarditis following the Moderna Spikevax COVID-19 vaccine is higher than what would be expected in the general population, particulary among males and females less than 40 years old and following the second dose.
Evidence is evolving and investigations into the association between myocarditis/pericarditis and mRNA vaccines continue.
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
Also from Canada:
Up to and including September 10, 2021, there are a total of 76 reports of GBS that met Level 1 to 4 of Brighton Collaboration level diagnostic certainty.. Of the GBS reports:
30 reports followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, 31 followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, and 15 followed vaccination with a Moderna Spikevax COVID-19 vaccine.
Current results show the rate of GBS following AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccination is higher than the rate of GBS following Pfizer-BioNTech Comirnaty COVID-19 vaccine or Moderna Spikevax COVID-19 vaccine. As well, the number of reports of GBS following AstraZeneca Vaxzevria/COVISHIELD vaccination are higher than would normally be expected in the general population.
Among the 30 reports of GBS following an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine:
Symptoms started between 6 hours and 25 days after vaccination
Median age is 55 years (age range 40 to 77 years old)
22 were males [median age 55 years (age range 40 to 66 years old)], 7 were females [median age 51 years (age range 40 to 77 years old)], and the age and sex of one was unspecified
21 reports following the first vaccine dose, and the dose number for 9 were unspecified
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
Thrombosis with thrombocytopenia syndrome (TTS) is characterized as blood clotting with low platelet levels.
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), also known as Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT), is characterized as TTS that seems to be vaccine-induced due to the laboratory-confirmed presence of platelet factor (PF) 4 antibodies.
Up to and including September 10, 2021, there were 81 reports of TTS that met Level 1 to 4 of Brighton Collaboration level of diagnostic certainty. Of the TTS reports:
61 reports followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, 16 followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, and four followed vaccination with a Moderna Spikevax COVID-19 vaccine.
Of the 61 TTS reports following a AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine:
Symptoms started between 1 and 37 days after vaccination.
Median age is 57 years (age range 19 to 88 years old)
32 were males [median age 57 years (age range 34 to 73 years old)], 28 were females [median age 56 years (age range 19 to 88 years old)], and the age and sex of one was not specified.
55 reports following the first vaccine dose, and the dose number for six were not specified
38 had laboratory results showing the presence of platelet factor (PF) 4 antibodies, indicating VITT (also known as VIPIT).
Six people died.
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
What this doctor is going through after the shot isn’t a walk through the park.
“My entire face felt like it was burning — like acid had been poured on my face. I had sensations throughout my body like it was vibrating. I felt like I had a tight band around my waist, chest pain and shortness of breath, and I went to bed for seven days.”
Canada has about 38 million people and is about 70% vaccinated against Covid.
Pfizer ~43 million doses distributed
Moderna ~18 million doses distributed
AstraZeneca ~3 million doses distributed
“Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine”
“Reports of lymphadenopathy were imbalanced with 58 more cases in the vaccine group (64) than the placebo group (6); lymphadenopathy is plausibly related to the vaccine. Lymphadenopathy occurred in the arm and neck region and was reported within 2 to 4 days after vaccination. The average duration of lymphadenopathy was approximately 10 days. Bell’s palsy was reported by four vaccine recipients and none of the placebo recipients.”
“The most common serious adverse events in the vaccine group which were numerically higher than in the placebo group were appendicitis (7 in vaccine vs 2 in placebo), acute myocardial infarction (3 vs 0), and cerebrovascular accident (3 vs 1).”
https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html
Those comments I believe are for less than 2000 patients.
Severe redness(>10cm) in 3 out of 1802 55+ patients.
“The Moderna COVID-19 Vaccine’s Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events”
“Reports of lymphadenopathy were imbalanced with 1.1 % of persons in the vaccine group and 0.6% in the placebo group reporting such events; lymphadenopathy is plausibly related to the vaccine. Lymphadenopathy occurred in the arm and neck region and was reported within 2 to 4 days after vaccination. The median duration of lymphadenopathy was 1 to 2 days. Bell’s palsy was reported by three vaccine recipients and one placebo recipient. One case of Bell’s palsy in the vaccine group was considered a serious adverse event.”
“The most common serious adverse events occurring at higher rates in the vaccine group than the placebo group were myocardial infarction (5 cases in vaccine group vs. 3 cases in placebo group), cholecystitis (3 vs. 0), and nephrolithiasis (3 vs. 0).”
https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html
Those comments I believe are for less than 3800 patients.
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
Recruiting
Sinai Hospital
Baltimore, Maryland, United States, 21215
https://clinicaltrials.gov/ct2/show/NCT04910971
COVID-19 Vaccines Safety Tracking (CoVaST)
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
Not yet recruiting
American College of Physicians
Philadelphia, Pennsylvania, United States, 19106
NCT04834869
Thnx for posting. Having a relation here in the UK who suffered Lymphadenopathy after the vaccine, I did some searching myself on investigations. I found this report very informative:
https://www.cambridge.org/core/services/aop-cambridge-core/content/view/EDFDC7E23E32A7246679127CDC16F441/S0022215121002462a.pdf/cervical-lymphadenopathy-following-coronavirus-disease-2019-vaccine-clinical-characteristics-and-implications-for-head-and-neck-cancer-services.pdf
It seems different vaccines have a significantly different incidence; between 50-60% fully resolved (the rest only partially) during the study period.
Makes no sense at all - new 1/3 dose shot for children up to age 11 and then at age 12 it’s a full dose. ?
And as far as I know, Pfizer and the CDC still aren’t lengthening the amount of time between the 1st & 2nd shots. More and more Dr’s are recommending waiting a few months between shots for better efficacy and fewer adverse effects.
Obviously you get paid by the post.
Nice side gig eh?
I know of two people personally who died from the jab.
And do not know of any who “died” from da covid. Of course, it is 99.9% survivable.
Talk to me in three years regarding your advocacy.
bkmk
Wow!
Now we are quoting the NY Times as an authoritative source?
“Vax” pimp’s gotta pimp.
They have no shame.
Heh heh - “It may kill you even when the bug would be handled easily - but it’s your duty to risk the jab and become part of the data set as we discover all the problems over the next 5-10 years...”
Funny thing is, vax rabbit. Vaxxing in the midst of a pandemic CREATES variants. You should bone up on the science before you pop off at the mouth.
Start with Darwin and 'survival of the fittest' and go from there.
#ScienceDenier
Any possibility this person also went by 2amendmentprotectstherest.
could be...
I had the same thought
Thanks for posting this. Eventually, this stuff must reach a critical mass among those few remaining people in government with any sort of conscience.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.